MedTrace Logo

Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat

NCT06244615 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2025-04-11

No results posted yet for this study

Summary

The aim of this study is to confirm the efficacy, safety and tolerability of the Mouth and Throat Rinse in adult participants with acute sore throat (upper respiratory tract infection e.g., pharyngitis/laryngitis) compared to placebo.

Conditions

  • Sore-throat
  • Upper Respiratory Infection

Interventions

DEVICE

Verum (WO 6607)

Mouth and throat rinse and gargle solution

DEVICE

Placebo (WO 6608)

Mouth and throat rinse and gargle solution

Sponsors & Collaborators

  • Pharmaxi LLC

    collaborator INDUSTRY

  • Labor Dr. Fenner und Kollegen

    collaborator UNKNOWN

  • Dr. August Wolff GmbH & Co. KG Arzneimittel

    lead INDUSTRY

Principal Investigators

  • Roman Fishchuk, MD · Central City Clinical Hospital of Ivano-Frankivsk

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-25
Primary Completion
2025-02-17
Completion
2025-02-17

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06244615 on ClinicalTrials.gov